Nasdaq

Longboard Stock Soars on FDA Designations for Epilepsy Drug

Shares of Longboard Pharmaceuticals LBPH gained 14% on Thursday after it announced that the FDA granted two designations — orphan drug and rare pediatric disease — to its lead pipeline drug ...
Hosted on MSN

Candel Therapeutics Stock Soars On FDA’s RMAT Designation For Prostate Cancer Therapy: Retail Considers It Good Long-Term Buy

Shares of Candel Therapeutics, Inc. (CADL) traded 8% higher on Wednesday morning after the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to ...
Investing.com Canada

Oculis stock surges after FDA grants breakthrough therapy designation

Investing.com -- Oculis Holding AG (NASDAQ:OCS) stock surged 9% on Tuesday after the FDA granted breakthrough therapy designation to its neuroprotective candidate Privosegtor for the treatment of ...
Mena FN

Senti Biosciences, Inc. (SNTI) Stock: Faces Decline Despite Groundbreaking FDA Designation

(MENAFN- Crypto Breaking) Biotech innovation continues to intersect with the broader world of digital transformation, influencing everything from AI driven drug discovery to investor sentiment across ...
Seeking Alpha

Immix gets FDA orphan drug designation for NXC-201, stock jumps

Immix Biopharma (NASDAQ:IMMX) said the FDA has granted orphan drug designation for its therapy candidate NXC-201 in the treatment of multiple myeloma. Shares of Immix were up 11% in afternoon trading ...
Seeking Alpha

Cartesian stock climbs 8% on FDA regenerative therapy designation

Shares of Cartesian Therapeutics (NASDAQ:RNAC) rose 8% in morning trading Wednesday after the company said it received FDA regenerative medicine advanced therapy, or RMAT, designation for its drug ...